(b)(4).Concomitant medical products: the patient¿s medications include; lasix, calcium, pradaxa, levothyroxine, protonix, valsartan and metoprolol.The review of the manufacturing paperwork verified that this lot met all pre-release specifications.According to the conformable gore® tag® thoracic endoprosthesis instructions for use, complications associated with the use of the gore® tag® thoracic endoprosthesis that may occur and/or require intervention include, but are not limited to persistent false lumen flow, dissection, perforation, or rupture of the aortic vessel & surrounding vasculature, and reoperation.
|
On (b)(6) 2018, the patient underwent endovascular treatment of a thoracic aortic dissection with a conformable gore® tag® thoracic endoprosthesis.It was reported the left subclavian artery was intentionally covered during the initial implantation procedure.On (b)(6) 2018, follow-up imaging identified distal false lumen perfusion within the treated area with distal extension of the dissection.On (b)(6) 2018, an intervention was performed, whereby an additional tag device was implanted for distal extension.According to the report, the physician was unable to determine if the false lumen perfusion was resolved at the conclusion of the procedure.Reportedly, the physician will continue to monitor the patient.The patient was reported to have tolerated the procedure.
|